Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

Published:2017-01 Issue:1 Volume:151 Page:106-118
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Mehta Sanjay,Sastry Bhagavatula Kutumba Srinivasa,Souza Rogério,Torbicki Adam,Ghofrani Hossein-Ardeschir,Channick Richard N.,Delcroix Marion,Pulido Tomás,Simonneau Gérald,Wlodarczyk John,Rubin Lewis J.,Jansa Pavel,Hunsche Elke,Galiè Nazzareno,Perchenet Loïc,Sitbon Olivier

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference27 articles.

1. Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives;Guillevin;Eur Respir Rev,2013

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

3. Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis;Benza;J Heart Lung Transplant,2015

4. Health-related quality of life in pulmonary arterial hypertension;Gihl;Adv Pulm Hypertens,2010

5. Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life: A systematic review;Rival;Chest,2014

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. The Management of Mild Pulmonary Hypertension in Clinical Practice;Annals of the American Thoracic Society;2024-08

4. Endothelin and the tumor microenvironment: a finger in every pie;Clinical Science;2024-05-24

5. Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension;Pulmonary Circulation;2023-07